|
2025-02-05 |
2025-02-04 |
PS
Planned sale
|
Naftzger J. Christopher
General Counsel and CCO
Officer
|
11,333
-11.6%
3.28
USD 37,206
|
11,333
-11.6%
|
3.28
|
USD 37,206
|
|
|
2025-02-05 |
2025-02-04 |
PS
Planned sale
|
Sims Karen
Chief Medical Officer
Officer
|
19,348
-15.4%
3.28
USD 63,519
|
19,348
-15.4%
|
3.28
|
USD 63,519
|
|
|
2025-02-05 |
2025-02-04 |
PS
Planned sale
|
McElhaugh Michael J.
Interim President & CEO
Executive Director
|
23,790
-1.6%
3.28
USD 78,103
|
23,790
-1.6%
|
3.28
|
USD 78,103
|
|
|
2025-02-05 |
2025-02-04 |
PS
Planned sale
|
HASTINGS DAVID C
Chief Financial Officer
Officer
|
22,183
-12.2%
3.28
USD 72,827
|
22,183
-12.2%
|
3.28
|
USD 72,827
|
|
|
2024-08-16 |
2024-08-14 |
S
Sale
|
MANCHESTER KEITH S
Non-Executive Director
|
8,846
-16.1%
3.69
USD 32,637
|
8,846
-16.1%
|
3.69
|
USD 32,637
|
|
|
2024-02-05 |
2024-02-02 |
PS
Planned sale
|
HASTINGS DAVID C
Chief Financial Officer
Officer
|
9,593
-5.0%
2.31
USD 22,184
|
9,593
-5.0%
|
2.31
|
USD 22,184
|
|
|
2024-02-05 |
2024-02-02 |
PS
Planned sale
|
Sofia Michael J.
Chief Scientific Officer
Officer
|
9,982
-0.7%
2.31
USD 23,083
|
9,982
-0.7%
|
2.31
|
USD 23,083
|
|
|
2024-02-05 |
2024-02-02 |
PS
Planned sale
|
McElhaugh Michael J.
Interim President & CEO
Executive Director
|
10,164
-0.7%
2.31
USD 23,504
|
10,164
-0.7%
|
2.31
|
USD 23,504
|
|
|
2024-02-05 |
2024-02-02 |
PS
Planned sale
|
Sims Karen
Chief Medical Officer
Officer
|
4,358
-3.4%
2.31
USD 10,078
|
4,358
-3.4%
|
2.31
|
USD 10,078
|
|
|
2021-12-03 |
2021-12-01 |
PS
Planned sale
|
Sofia Michael J.
Chief Scientific Officer
Officer
|
200,000
-13.3%
5.09
USD 1,018,000
|
200,000
-13.3%
|
5.09
|
USD 1,018,000
|
|
|
2021-02-10 |
2021-02-09 |
PS
Planned sale
|
McElhaugh Michael J.
Chief Business Officer
Officer
|
20,000
-1.5%
5.00
USD 100,000
|
20,000
-1.5%
|
5.00
|
USD 100,000
|
|
|
2020-12-16 |
2020-12-14 |
PS
Planned sale
|
McElhaugh Michael J.
Chief Business Officer
Officer
|
10,000
-0.7%
5.00
USD 50,032
|
10,000
-0.7%
|
5.00
|
USD 50,032
|
|
|
2020-12-16 |
2020-12-14 |
PS
Planned sale
|
McElhaugh Michael J.
Chief Business Officer
Officer
|
30,000
-2.2%
5.00
USD 150,000
|
30,000
-2.2%
|
5.00
|
USD 150,000
|
|
|
2020-07-27 |
2020-07-23 |
PS
Planned sale
|
McElhaugh Michael J.
Chief Business Officer
Officer
|
20,000
-1.4%
5.01
USD 100,200
|
20,000
-1.4%
|
5.01
|
USD 100,200
|
|
|
2018-08-14 |
2018-08-13 |
S
Sale
|
Sofia Michael J.
Chief Scientific Officer
Officer
|
4,250
-0.3%
9.51
USD 40,436
|
4,250
-0.3%
|
9.51
|
USD 40,436
|
|
|
2018-07-13 |
2018-07-11 |
PS
Planned sale
|
Sofia Michael J.
Chief Scientific Officer
Officer
|
10,000
-0.7%
10.00
USD 100,000
|
10,000
-0.7%
|
10.00
|
USD 100,000
|
|
|
2018-07-10 |
2018-07-09 |
PS
Planned sale
|
Sofia Michael J.
Chief Scientific Officer
Officer
|
10,000
-0.7%
8.91
USD 89,060
|
10,000
-0.7%
|
8.91
|
USD 89,060
|
|
|
2018-07-10 |
2018-07-06 |
PS
Planned sale
|
Sofia Michael J.
Chief Scientific Officer
Officer
|
10,000
-0.7%
8.45
USD 84,500
|
10,000
-0.7%
|
8.45
|
USD 84,500
|
|
|
2018-07-06 |
2018-07-05 |
PS
Planned sale
|
Sofia Michael J.
Chief Scientific Officer
Officer
|
10,000
-0.6%
8.40
USD 84,000
|
10,000
-0.6%
|
8.40
|
USD 84,000
|
|
|
2018-07-06 |
2018-07-03 |
PS
Planned sale
|
Sofia Michael J.
Chief Scientific Officer
Officer
|
10,000
-0.6%
8.00
USD 80,000
|
10,000
-0.6%
|
8.00
|
USD 80,000
|
|
|
2017-10-05 |
2017-10-03 |
PS
Planned sale
|
Sofia Michael J.
Chief Scientific Officer
Officer
|
10,000
-0.6%
8.00
USD 80,000
|
10,000
-0.6%
|
8.00
|
USD 80,000
|
|
|
2017-08-17 |
2017-08-15 |
S
Sale
|
Sofia Michael J.
Chief Scientific Officer
|
20,000
-10.4%
3.68
USD 73,500
|
20,000
-10.4%
|
3.68
|
USD 73,500
|
|
|
2017-08-17 |
2017-08-15 |
S
Sale
|
Sofia Michael J.
Chief Scientific Officer
|
10,000
-5.0%
3.75
USD 37,500
|
10,000
-5.0%
|
3.75
|
USD 37,500
|
|
|
2015-08-26 |
2015-08-24 |
B
Purchase
|
HENRIQUES RICHARD C JR
Non-Executive Director
|
1,000
+inf%
6.95
USD 6,950
|
1,000
+inf%
|
6.95
|
USD 6,950
|
|
